Related references
Note: Only part of the references are listed.A Randomised Controlled Trial Assessing the Effects of Peri-operative Fenofibrate Administration on Abdominal Aortic Aneurysm Pathology: Outcomes From the FAME Trial
Joseph Moxon et al.
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2020)
Fenofibrate improves vascular endothelial function and contractility in diabetic mice
Nan Xu et al.
REDOX BIOLOGY (2019)
Molecular association model of PPAR alpha and its new specific and efficient ligand, pemafibrate: Structural basis for SPPARM alpha
Yuta Yamamoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Efficacy and Safety of Pemafibrate Versus Fenofibrate in Patients with High Triglyceride and Low HDL Cholesterol Levels: A Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Hidenori Arai et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2018)
Efficacy and safety of pemafibrate (K-877), a selective peroxisome proliferator-activated receptor alpha modulator, in patients with dyslipidemia: Results from a 24-week, randomized, double blind, active-controlled, phase 3 trial
Shun Ishibashi et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2018)
Modulation of Immune-Inflammatory Responses in Abdominal Aortic Aneurysm: Emerging Molecular Targets
Hanrong Li et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Randomized Placebo-Controlled Trial Assessing the Effect of 24-Week Fenofibrate Therapy on Circulating Markers of Abdominal Aortic Aneurysm: Outcomes From the FAME-2 Trial
Jenna L. Pinchbeck et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Risk of abdominal aortic aneurysm (AAA) among male and female relatives of AAA patients
Koen M. van de Luijtgaarden et al.
VASCULAR MEDICINE (2017)
Identification and Characterization of Fenofibrate-Induced Liver Injury
Jawad Ahmad et al.
DIGESTIVE DISEASES AND SCIENCES (2017)
The novel selective PPARα modulator (SPPARMα) pemafibrate improves dyslipidemia, enhances reverse cholesterol transport and decreases inflammation and atherosclerosis
Nathalie Hennuyer et al.
ATHEROSCLEROSIS (2016)
Transcriptome Analysis of K-877 (a Novel Selective PPAR alpha Modulator (SPPARM alpha))-Regulated Genes in Primary Human Hepatocytes and the Mouse Liver
Sana Raza-Iqbal et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2015)
Selective peroxisome proliferator-activated receptora modulators (SPPARMα): The next generation of peroxisome proliferator-activated receptor α-agonists
Jean-Charles Fruchart
CARDIOVASCULAR DIABETOLOGY (2013)
Surveillance Intervals for Small Abdominal Aortic Aneurysms: A Meta-analysis
M.J. Bown et al.
JOURNAL OF VASCULAR SURGERY (2013)
Fenofibrate Increases High-Density Lipoprotein and Sphingosine 1 Phosphate Concentrations Limiting Abdominal Aortic Aneurysm Progression in a Mouse Model
Smriti M. Krishna et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Reversibility of Fenofibrate Therapy-Induced Renal Function Impairment in ACCORD Type 2 Diabetic Participants
Josyf C. Mychaleckyj et al.
DIABETES CARE (2012)
Doxycycline Does Not Influence Established Abdominal Aortic Aneurysms in Angiotensin II-Infused Mice
Xiaojie Xie et al.
PLOS ONE (2012)
Effect of fenofibrate treatment for hyperlipidaemia on serum creatinine and cystatin C
Vusumuzi Ncube et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2012)
Abdominal Aortic Aneurysm Is Associated with a Variant in Low-Density Lipoprotein Receptor-Related Protein 1
Matthew J. Bown et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2011)
Systematic review and meta-analysis of growth rates of small abdominal aortic aneurysms
J. T. Powell et al.
BRITISH JOURNAL OF SURGERY (2011)
Peroxisome proliferator-activated receptor ligands reduce aortic dilatation in a mouse model of aortic aneurysm
Jonathan Golledge et al.
ATHEROSCLEROSIS (2010)
Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm
Solveig Gretarsdottir et al.
NATURE GENETICS (2010)
Peroxisome Proliferator-Activated Receptor Alpha Target Genes
Maryam Rakhshandehroo et al.
PPAR RESEARCH (2010)
PPARα activator fenofibrate modulates angiotensin II-induced inflammatory responses in vascular smooth muscle cells via the TLR4-dependent signaling pathway
Yuan-Yuan Ji et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Risk Factors for Abdominal Aortic Aneurysms A 7-Year Prospective Study: The Tromso Study, 1994-2001
Signe Helene Forsdahl et al.
CIRCULATION (2009)
Identification of a genetic variant associated with abdominal aortic aneurysms on chromosome 3p12.3 by genome wide association
James R. Elmore et al.
JOURNAL OF VASCULAR SURGERY (2009)
The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm
Anna Helgadottir et al.
NATURE GENETICS (2008)
Traditional and novel risk factors for clinically diagnosed abdominal aortic aneurysm: The Kaiser Multiphasic Health Checkup cohort study
Carlos Iribarren et al.
ANNALS OF EPIDEMIOLOGY (2007)
Smoking, hypertension, alcohol consumption, and risk of abdominal aortic aneurysm in men
Daniel R. Wong et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
The pro-inflammatory and chemotactic cytokine microenvironment of the abdominal aortic aneurysm wall: A protein array study
Rachel K. Middleton et al.
JOURNAL OF VASCULAR SURGERY (2007)
Role of oxidative stress in the pathogenesis of abdominal aortic aneurysms
Michael L. McCormick et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Fenofibrate reduces atherogenesis in ApoE*3Leiden mice - Evidence for multiple antiatherogenic effects besides lowering plasma cholesterol
T. Kooistra et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Rapid dilation of the abdominal aorta during infusion of angiotensin II detected by noninvasive high-frequency ultrasonography
Chiara Barisione et al.
JOURNAL OF VASCULAR SURGERY (2006)
Middle age cardiovascular risk factors and abdominal aortic aneurysm in older age
MB Rodin et al.
HYPERTENSION (2003)
Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms
MW Manning et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Doxycycline in patients with abdominal aortic aneurysms and in mice: Comparison of serum levels and effect on aneurysm growth in mice
AK Prall et al.
JOURNAL OF VASCULAR SURGERY (2002)
Oxidative stress in human abdominal aortic aneurysms - A potential mediator of aneurysmal remodeling
FJ Miller et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
A potent PPARα agonist stimulates mitochondrial fatty acid β-oxidation in liver and skeletal muscle
A Minnich et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2001)
The ligands/activators for peroxisome proliferator-activated receptor alpha (PPAR alpha) and PPAR gamma increase Cu2+,Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells
I Inoue et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2001)
The PPARs: From orphan receptors to drug discovery
TM Willson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Share Paper
